Literature DB >> 19786287

Convergence in the biosynthesis of acetogenic natural products from plants, fungi, and bacteria.

Gerhard Bringmann1, Andreas Irmer, Doris Feineis, Tobias A M Gulder, Hans-Peter Fiedler.   

Abstract

This review deals with polyketides to which nature has developed different biosynthetic pathways in the course of evolution. The anthraquinone chrysophanol is the first example of an acetogenic natural product that is, in an organism-specific manner, formed via more than one polyketide folding mode: In eukaryotes, like e.g., in fungi, in higher plants, and in insects, it is synthesized via folding mode F, while in prokaryotes it originates through mode S. It has, more recently, even been found to be synthesized by a third pathway, named mode S'. Thus, chrysophanol is the first polyketide synthase product that originates through a divergent-convergent biosynthesis (depending on the respective producing organisms). A second example of a striking biosynthetic convergence is the isoquinoline alkaloids. While all as yet investigated representatives of this large family of plant-derived metabolites (more than 2500 known representatives!) are formed from aromatic amino acids, the biosynthetic origin of naphthylisoquinoline alkaloids like dioncophylline A is unprecedented in following a route to isoquinolines in plants: we have shown that such naphthylisoquinolines represent the as yet only known polyketidic di- and tetrahydroisoquinolines, originating from acetate and malonate units, exclusively. Both molecular halves, the isoquinoline part and the naphthalene portion, are even synthesized from a joint polyketide precursor, the first proven case of the F-type folding mode in higher plants. The biosynthetic origins of the natural products presented in this paper were elucidated by feeding (13)C(2)-labeled acetate (or advanced precursors) to the respective producing organisms, with subsequent NMR analysis of their (13)C(2) incorporation patterns using the potent cryoprobe methodology, thus making the full polyketide folding pattern visible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786287     DOI: 10.1016/j.phytochem.2009.08.019

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  6 in total

1.  Recent total syntheses of anthraquinone-based natural products.

Authors:  Jackson A Gartman; Uttam K Tambar
Journal:  Tetrahedron       Date:  2022-01-11       Impact factor: 2.457

2.  Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.

Authors:  Kun-Che Chang; Linfeng Li; Theresa M Sanborn; Biehuoy Shieh; Patricia Lenhart; David Ammar; Daniel V LaBarbera; J Mark Petrash
Journal:  J Nat Prod       Date:  2016-05-03       Impact factor: 4.050

Review 3.  Anthraquinones and Derivatives from Marine-Derived Fungi: Structural Diversity and Selected Biological Activities.

Authors:  Mireille Fouillaud; Mekala Venkatachalam; Emmanuelle Girard-Valenciennes; Yanis Caro; Laurent Dufossé
Journal:  Mar Drugs       Date:  2016-03-25       Impact factor: 5.118

4.  Sea foam as a source of fungal inoculum for the isolation of biologically active natural products.

Authors:  David P Overy; Fabrice Berrue; Hebelin Correa; Novriyandi Hanif; Kathryn Hay; Martin Lanteigne; Kathrine Mquilian; Stephanie Duffy; Patricia Boland; Ramesh Jagannathan; Gavin S Carr; Marieke Vansteeland; Russell G Kerr
Journal:  Mycology       Date:  2014-07-09

5.  An Unusually Broad Series of Seven Cyclombandakamines, Bridged Dimeric Naphthylisoquinoline Alkaloids from the Congolese Liana Ancistrocladus ealaensis.

Authors:  Dieudonné Tshitenge Tshitenge; Torsten Bruhn; Doris Feineis; Virima Mudogo; Marcel Kaiser; Reto Brun; Gerhard Bringmann
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

6.  Bioactive Bianthraquinones and Meroterpenoids from a Marine-Derived Stemphylium sp. Fungus.

Authors:  Ji-Yeon Hwang; Sung Chul Park; Woong Sub Byun; Dong-Chan Oh; Sang Kook Lee; Ki-Bong Oh; Jongheon Shin
Journal:  Mar Drugs       Date:  2020-08-21       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.